Irhythm Holdings Inc IRTC

$127.80 +3.81 (3.07%)

Valuation

Market cap
4,087,083,000
Revenue TTM
$747,140,000
Net income TTM
$-44,550,000
PE ratio
269.02
Forward PE
229.17
Profit margin
-5.96%
Debt to equity
0.00

Trading

Volume
550,200
Avg volume
501,524
Day's range
$125.11 – $128.34
Shares out
32,963,000
Stochastic %K
97%
Beta
1.45
Analysts
Strong Sell
Price target
$168.24

Price

Company profile

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also prov...

Show more

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Industry
Medical Devices
Sector
Healthcare
Phone
415 632 5700
Website
https://www.irhythmtech.com
Address
699 8th Street, Suite 600, San Francisco, United States

Latest news

Stocktwits

thatsolardude365 Oct 30, 1:52 AM
$IRTC: 7 days to the Nov 5 final approval hearing in the $45M iRhythm Zio AT deal. Plaintiffs allege false statements about near real-time data for high-risk patients. Claims closed Oct 1. Open Class Actions.
0 replies
thatsolardude365 Oct 28, 1:36 PM
$IRTC: filed in the $45M iRhythm deal? Small claims may get nothing. Payouts under $10 are not issued, and the estimate is about $1.83 a share before fees. Claims closed Oct 1, approval pending. Open Class Actions.
0 replies
11thestate Oct 28, 12:38 PM
Imagine buying $IRTC at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $IRTC investors: there's a $45 million investor settlement, and late claims are currently being considered. If you purchased shares between 2022 and 2024, you may still be eligible to participate. You can check your eligibility and submit a late claim here: https://11th.com/cases/irhythm-investor-settlement
0 replies
thatsolardude365 Oct 27, 5:03 AM
$IRTC: Nov 5 is decision day in the $45M iRhythm deal. Judge Corley hears final approval by Zoom at 9 a.m. Pacific. Lead counsel seeks 25% fees, about $0.49 a share in costs. Claims closed Oct 1. Open Class Actions.
0 replies
thatsolardude365 Oct 26, 12:13 AM
$IRTC: leftover money in the $45M iRhythm deal has a second act. About 6 months after the first payout, remaining funds may go again to claimants who cashed checks. Claims closed, Nov 5 hearing next. Open Class Actions.
0 replies
thatsolardude365 Oct 24, 7:56 PM
$IRTC: bought iRhythm July 25, 2022 to Aug 9, 2024? Shares sold before the close on Nov 1, 2022 count as $0 recognized loss in the $45M Zio AT deal. Claims closed Oct 1, Nov 5 hearing is next. Open Class Actions.
0 replies
thatsolardude365 Oct 23, 4:03 PM
$IRTC: filed in the $45M iRhythm settlement? Small claims get nothing: distributions under $10 are not paid and go to larger claimants instead. Claims closed Oct 1, Nov 5 approval hearing is next. Open Class Actions.
0 replies
thatsolardude365 Oct 22, 7:11 AM
$IRTC: fees come off the top in the $45M iRhythm settlement. Counsel seeks up to $11.25M plus $800K expenses, about $0.49 a share against the $1.83 estimated average. Nov 5 hearing decides it. Claims closed. Open Class Actions.
0 replies